These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 30584434)

  • 1. Outcomes of a Longitudinal Population-based Cohort Study and Pragmatic Community Trial: Findings from 20 Years of the Tehran Lipid and Glucose Study.
    Khalili D; Azizi F; Asgari S; Zadeh-Vakili A; Momenan AA; Ghanbarian A; Eskandari F; Sheikholeslami F; Hadaegh F
    Int J Endocrinol Metab; 2018 Oct; 16(4 Suppl):e84748. PubMed ID: 30584434
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contributions and Implications of the Tehran Lipid and Glucose Study.
    Azizi F; Takyar M; Zadeh-Vakili A
    Int J Endocrinol Metab; 2018 Oct; 16(4 Suppl):e84792. PubMed ID: 30584448
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Review of Rationale, Design, and Initial Findings: Tehran Lipid and Glucose Study.
    Azizi F; Zadeh-Vakili A; Takyar M
    Int J Endocrinol Metab; 2018 Oct; 16(4 Suppl):e84777. PubMed ID: 30584442
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biochemical Assessment: Findings from 20 Years of the Tehran Lipid and Glucose Study.
    Hedayati M; Daneshpour MS; Zarkesh M; Zarif Yeganeh M; Sheikholeslami S; Faam B; Azizi F
    Int J Endocrinol Metab; 2018 Oct; 16(4 Suppl):e84783. PubMed ID: 30584444
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blood Pressure and Hypertension: Findings from 20 Years of the Tehran Lipid and Glucose Study (TLGS).
    Abdi H; Amouzegar A; Tohidi M; Azizi F; Hadaegh F
    Int J Endocrinol Metab; 2018 Oct; 16(4 Suppl):e84769. PubMed ID: 30584437
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rationale and Design of a Genetic Study on Cardiometabolic Risk Factors: Protocol for the Tehran Cardiometabolic Genetic Study (TCGS).
    Daneshpour MS; Fallah MS; Sedaghati-Khayat B; Guity K; Khalili D; Hedayati M; Ebrahimi A; Hajsheikholeslami F; Mirmiran P; Ramezani Tehrani F; Momenan AA; Ghanbarian A; Amouzegar A; Amiri P; Azizi F
    JMIR Res Protoc; 2017 Feb; 6(2):e28. PubMed ID: 28232301
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Impact of Physical Activity on Non-communicable Diseases: Findings from 20 Years of the Tehran Lipid and Glucose Study.
    Sheikholeslami S; Ghanbarian A; Azizi F
    Int J Endocrinol Metab; 2018 Oct; 16(4 Suppl):e84740. PubMed ID: 30584431
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bibliometric overview of the Tehran Lipid and Glucose Study (TLGS) publications from 2000 to 2022.
    Rezaeizadeh F; Ghazbani A; Nouri M; Bahadoran Z; Mansourzadeh MJ; Khalili D
    J Diabetes Metab Disord; 2024 Jun; 23(1):343-351. PubMed ID: 38932887
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term incidence of cardiovascular outcomes in the middle-aged and elderly with different patterns of physical activity: Tehran lipid and glucose study.
    Naseri P; Amiri P; Masihay-Akbar H; Jalali-Farahani S; Khalili D; Azizi F
    BMC Public Health; 2020 Nov; 20(1):1654. PubMed ID: 33148219
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reproductive Assessment: Findings from 20 Years of the Tehran Lipid and Glucose Study.
    Ramezani Tehrani F; Behboudi-Gandevani S; Rostami Dovom M; Farahmand M; Minooee S; Noroozzadeh M; Amiri M; Nazarpour S; Azizi F
    Int J Endocrinol Metab; 2018 Oct; 16(4 Suppl):e84786. PubMed ID: 30584446
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum Lipids During 20 Years in the Tehran Lipid and Glucose Study: Prevalence, Trends and Impact on Non-Communicable Diseases.
    Baghbani-Oskouei A; Tohidi M; Asgari S; Ramezankhani A; Azizi F; Hadaegh F
    Int J Endocrinol Metab; 2018 Oct; 16(4 Suppl):e84750. PubMed ID: 30584435
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Data-driven phenomapping for novel classification for cardiovascular outcomes compared with traditional obesity index: Tehran Lipid and Glucose Study.
    Zare Borzeshi E; Valizadeh M; Panahi MH; Khalili D; Mousavizadeh M; Mehrabi Y
    BMJ Open; 2023 Jun; 13(6):e071011. PubMed ID: 37316323
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diabetes Mellitus: Findings from 20 Years of the Tehran Lipid and Glucose Study.
    Ramezankhani A; Harati H; Bozorgmanesh M; Tohidi M; Khalili D; Azizi F; Hadaegh F
    Int J Endocrinol Metab; 2018 Oct; 16(4 Suppl):e84784. PubMed ID: 30584445
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictive accuracy of the 'Framingham's general CVD algorithm' in a Middle Eastern population: Tehran Lipid and Glucose Study.
    Bozorgmanesh M; Hadaegh F; Azizi F
    Int J Clin Pract; 2011 Mar; 65(3):264-73. PubMed ID: 21314863
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factor analysis of metabolic syndrome components and predicting type 2 diabetes: Results of 10-year follow-up in a Middle Eastern population.
    Ayubi E; Khalili D; Delpisheh A; Hadaegh F; Azizi F
    J Diabetes; 2015 Nov; 7(6):830-8. PubMed ID: 25492310
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predisposing factors of long-term responsiveness in a cardio-metabolic cohort: Tehran Lipid and Glucose Study.
    Cheraghi L; Amiri P; Vahedi-Notash G; Jalali-Farahani S; Khalili D; Azizi F
    BMC Med Res Methodol; 2021 Aug; 21(1):161. PubMed ID: 34372764
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distribution of blood pressure and prevalence of hypertension in Tehran adult population: Tehran Lipid and Glucose Study (TLGS), 1999-2000.
    Azizi F; Ghanbarian A; Madjid M; Rahmani M
    J Hum Hypertens; 2002 May; 16(5):305-12. PubMed ID: 12082490
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overweight and Obesity: Findings from 20 Years of the Tehran Lipid and Glucose Study.
    Barzin M; Valizadeh M; Serahati S; Mahdavi M; Azizi F; Hosseinpanah F
    Int J Endocrinol Metab; 2018 Oct; 16(4 Suppl):e84778. PubMed ID: 30584443
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cohort profile update: Tehran cardiometabolic genetic study.
    Daneshpour MS; Akbarzadeh M; Lanjanian H; Sedaghati-Khayat B; Guity K; Masjoudi S; Zahedi AS; Moazzam-Jazi M; Bonab LNH; Shalbafan B; Asgarian S; Farhood GK; Javanrooh N; Zarkesh M; Riahi P; Moghaddas MR; Dehkordi PA; Ahmadi AD; Hosseini F; Farahani SJ; Hadaegh F; Mirmiran P; Tehrani FR; Ghanbarian A; Pasand MSFM; Amiri P; Valizadeh M; Hosseipanah F; Tohidi M; Ghasemi A; Zadeh-Vakili A; Piryaei M; Alamdari S; Khalili D; Momenan A; Barzin M; Zeinali S; Hedayati M; Azizi F
    Eur J Epidemiol; 2023 Jun; 38(6):699-711. PubMed ID: 37169991
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk of hypertension in school-aged children undergoing a long-term community-based lifestyle intervention: Tehran Lipid and Glucose Study.
    Mansouri-Tehrani MM; Amiri P; Cheraghi L; Masihay-Akbar H; Mirmiran P; Azizi F
    Prev Med; 2021 Dec; 153():106799. PubMed ID: 34506814
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.